Cargando…
Acute Encephalopathy Due to Polypharmacy Interactions With the Use of Paxlovid: A Case Report
Paxlovid is an oral therapy in the treatment of COVID-19. It has been authorized by the Food and Drug Administration (FDA) to be used under the Emergency Use Authorization Act (EUAA) for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121263/ https://www.ncbi.nlm.nih.gov/pubmed/37090279 http://dx.doi.org/10.7759/cureus.36535 |